We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
-1.47%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$7.91B
AUM Growth
-$1.76B
Cap. Flow
-$1.37B
Cap. Flow %
-17.29%
Top 10 Hldgs %
11.41%
Holding
2,902
New
788
Increased
705
Reduced
576
Closed
758

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$52.3M
2
EXC icon
Exelon
EXC
+$51.9M
3
LIN icon
Linde
LIN
+$48.3M
4
AMD icon
Advanced Micro Devices
AMD
+$41.5M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$39.8M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$251M
2
MSFT icon
Microsoft
MSFT
+$235M
3
AMZN icon
Amazon
AMZN
+$226M
4
CSGP icon
CoStar Group
CSGP
+$103M
5
AER icon
AerCap
AER
+$82.2M

Sector Composition

Rank Sector Weight
1 Technology 13.96%
2 Industrials 12.92%
3 Consumer Discretionary 9.79%
4 Financials 9.27%
5 Energy 7.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
POWI icon
2576
Power Integrations
POWI
$3.08B
-33,093
Closed -$3.07M
PPG icon
2577
PPG Industries
PPG
$25.3B
-71,895
Closed -$12.4M
PRIM icon
2578
Primoris Services
PRIM
$4.15B
-18,130
Closed -$435K
PRLD icon
2579
Prelude Therapeutics
PRLD
$529M
-20,773
Closed -$259K
PROK icon
2580
ProKidney
PROK
$336M
-50,000
Closed -$495K
PRU icon
2581
Prudential Financial
PRU
$41.8B
-16,071
Closed -$1.74M
PSA icon
2582
Public Storage
PSA
$60.2B
-5,323
Closed -$1.99M
PSEC icon
2583
Prospect Capital
PSEC
$1.17B
-21,364
Closed -$180K
PSMT icon
2584
Pricesmart
PSMT
$5.33B
-7,168
Closed -$524K
PYXS icon
2585
Pyxis Oncology
PYXS
$257M
-249,762
Closed -$2.74M
PYPL icon
2586
PayPal
PYPL
$52.7B
-119,347
Closed -$15.9M
QNCX icon
2587
Quince Therapeutics
QNCX
$34.5M
-153
Closed -$385K
QRVO icon
2588
Qorvo
QRVO
$8.43B
-10,189
Closed -$1.59M
QS icon
2589
QuantumScape Corp
QS
$3.68B
-126,719
Closed -$2.81M
QSR icon
2590
Restaurant Brands International
QSR
$28.2B
-33,654
Closed -$2.04M
QUAD icon
2591
PUT
Quad
QUAD
$532M
-44,100
Closed -$176K
QURE icon
2592
uniQure
QURE
$3.36B
-34,637
Closed -$718K
R icon
2593
Ryder
R
$9.58B
-2,996
Closed -$247K
RAPT
2594
DELISTED
RAPT Therapeutics
RAPT
-827
Closed -$243K
RBBN icon
2595
Ribbon Communications
RBBN
$363M
-31,484
Closed -$190K
REGN icon
2596
Regeneron Pharmaceuticals
REGN
$85.9B
-1,918
Closed -$1.21M
REM icon
2597
iShares Mortgage Real Estate ETF
REM
$544M
-16,663
Closed -$575K
RENT
2598
Rent the Runway
RENT
$128M
-546
Closed -$89K
RGEN icon
2599
Repligen
RGEN
$10.2B
-47,805
Closed -$12.7M
RGLD icon
2600
Royal Gold
RGLD
$21.9B
-18,467
Closed -$1.94M

Similar funds

Michael Gelband's Q1 2022 Portfolio in Review

As of Q1 2022, Michael Gelband held 2,902 positions worth $7.91B, down 18% from $9.67B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Michael Gelband withdrew a net $1.37B in Q1 2022, closing 758 positions and reducing 576 holdings. Its most notable exit was CoStar Group, an estimated $103M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Michael Gelband opened a new position in Linde worth $49.9M.

  • Michael Gelband's largest Q1 2022 buy was Linde: 156,289 shares worth $49.9M.
  • Michael Gelband added most to ExxonMobil in Q1 2022, an estimated $52.3M increase.
  • Michael Gelband's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $251M.
  • Michael Gelband fully exited CoStar Group in Q1 2022, selling an estimated $103M.
  • Michael Gelband's ten largest holdings make up 11% of its $7.91B portfolio in Q1 2022.
  • Michael Gelband opened 788 new positions and closed 758 in Q1 2022.
  • Michael Gelband's portfolio value fell 18% quarter-over-quarter to $7.91B.

Based on ExodusPoint Capital Management's 13F filing for Q1 2022, filed 13 May 2022.